No Prescription |
 |
 | ||
|
ACERET Soriatane |
|
| ||
No Prescription » Prescription Drugs 1 » ACERET Soriatane This medication is a retinoid used in the treatment of severe psoriasis and other skin disorders in adults.How to use Acitretin OralRead the Medication Guide provided by your pharmacist before you start using acitretin and each time you get a refill. If you have any questions regarding the information consult your doctor or pharmacist.Read and complete the Patient Agreement and Informed Consent document before taking this drug.Take this medication by mouth exactly as prescribed usually once a day with your main meal.The dosage is based on your medical condition and response to therapy. Do not take this more often or increase your dose without consulting your doctor. Your condition will not improve any faster but the risk of side effects may increase.It may take 2 to 3 months before the full benefit of this medication is seen.Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time each day.What conditions does this medication treat?Acitretin Oral is used to treat the following:Severe Psoriasis that is Resistant to TreatmentAcitretin Oral may also be used to treat:A Group of Lymphomas of the Skin Skin Disease Characterized by Swollen Itching Lesions Ichthyosis Lamellar Ichthyosiform Erythroderma A Rare Hereditary Skin Condition Buy ACERET Soriatane and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About ACERET Soriatane: Product Type: Prescription Drugs 1 ACERET ( Soriatane Generic Acitretin ) ACERET (Soriatane Generic Acitretin) Soriatane Generic Acitretin 25mg 30 Capsules 25mg 10 Capsules 25mg 20 Capsules Soriatane Generic Acitretin ACERET
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
